Essential Hypertension: all 538 studies

Page 6 of 6. Open to participants first (76), then studies with results posted, then the rest; newest registration first within each.

• Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential HypertensionCompletedNCT00355589Phase 3
• Effects of Inhibition of NO-Synthesis on Renal Hemodynamics and Sodium Excretion in Patients With Essential Hypertension and Healthy ControlsCompletedNCT00345150Phase 1
• The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Essential HypertensionCompletedNCT00345124Not applicable
• Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential HypertensionCompletedNCT00344110Phase 3
• Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.CompletedNCT00343551Phase 3
• Long Term Study of VAH631 in Patients With Essential Hypertension (Extension From B1303 Study)CompletedNCT00338936Phase 3
• Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In KoreaCompletedNCT00328965Phase 4
• A Study of VAH631 in Patients With Essential Hypertension (Factorial Study)CompletedNCT00311740Phase 3
• Autonomic Imbalance and 24-h Blood Pressure Change in Patients With Chronic Renal DiseaseCompletedNCT00298129
• Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic NephropathyCompletedNCT00295555Phase 4
• Uric Acid in Essential Hypertension in ChildrenCompletedNCT00288184Phase 2
• Heart Rate Variability in White Coat Hypertension and Essential HypertensionCompletedNCT00286884
• Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential HypertensionCompletedNCT00257491Phase 3
• A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and HypercholesterolemiaCompletedNCT00254475Phase 3
• A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)CompletedNCT00246584Phase 2
• A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential HypertensionCompletedNCT00236665Phase 3
• Olmesartan as an add-on to Amlodipine in HypertensionCompletedNCT00220233Phase 3
• Amlodipine as add-on to Olmesartan in HypertensionCompletedNCT00220220Phase 3
• Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential HypertensionCompletedNCT00219037Phase 3
• Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension.CompletedNCT00219024Phase 3
• Motivational InterviewingTerminatedNCT00208104Not applicable
• Olmesartan Medoxomil in AtherosclerosisCompletedNCT00185185Phase 3
• Olmesartan in Essential HypertensionCompletedNCT00185172Phase 3
• A Study of Nifecardia SRFC and Adalat OROS in the Treatment of Patients With Essential HypertensionStatus unknownNCT00173667Phase 4
• Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)CompletedNCT00157963Phase 4
• 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential HypertensionCompletedNCT00153049Phase 2
• Olmesartan Medoxomil in Hypertension and Renal ImpairmentCompletedNCT00151827Phase 3
• The Renin-Angiotensin System in Essential HypertensionTerminatedNCT00141583Not applicable
• Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential HypertensionCompletedNCT00139698Phase 3
• Effectiveness of Eplerenone to Improve Target Organ Damage in Patients With Resistant Arterial HypertensionCompletedNCT00138944Phase 3
• L-Arginine Metabolism in Essential HypertensionCompletedNCT00137124Phase 2/3
• Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide Diuretics in Hypertensive PatientsCompletedNCT00135551Phase 4
• Diuretics In the Management of Essential Hypertension (DIME) StudyCompletedNCT00131846Phase 4
• Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential HypertensionCompletedNCT00130156Phase 4
• Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive WomenCompletedNCT00102141Phase 3
• Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)CompletedNCT00092209Phase 3
• Hypertension: Prediction of Biofeedback SuccessCompletedNCT00026065Phase 1
• Role of Endothelin in the Regulation of Vascular Tone in Patients With Essential HypertensionCompletedNCT00001527

← Essential Hypertension overview